Lindy Biosciences, Inc. — Form D
Lindy Biosciences, Inc. of Morrisville, NC, a company, filed a Form D exempt-offering notice with the SEC on 2018-03-16. The offering totals $150K, of which $150K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-03-16
- Form: D
- Accession: 0001731038-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $150K
- Amount sold: $150K
- Investors: 1
- Date of first sale: 2018-03-06
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-307909
Issuer
- Name: Lindy Biosciences, Inc.
- CIK: 0001731038
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 627 Davis Drive, Morrisville, NC, 27560
- Phone: 919-765-8700
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Joel Whitley | Director | Wayne, PA |
| Sreekar Gadde | Director | Chagrin Falls, OH |
| Karen LeVert | Director | Morrisville, NC |
| Karen LeVert | Executive Officer | Morrisville, NC |
| Omar Flores | Director | Morrisville, NC |
| Omar Flores | Executive Officer | Morrisville, NC |
| Deborah Bitterfield | Director | Morrisville, NC |
| Deborah Bitterfield | Executive Officer | Morrisville, NC |
| Deborah Bitterfield | Promoter | Morrisville, NC |
Other filings by this issuer (3)
More